Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines！Free Sample is available！ Here come GMP Grade Cytokines！Free Sample is available！
The purity of Mouse NPR1 Protein, His Tag (Cat. No. NP1-M52H3) is more than 90% and the molecular weight of this protein is around 110-150 kDa verified by SEC-MALS.
The purity of Biotinylated Human NPR1, His,Avitag (Cat. No. NP1-H82E9) is more than 85% and the molecular weight of this protein is around 65-80 kDa verified by SEC-MALS.
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Recombinant human brain natriuretic peptide (Tibet Rhodiola) | Approved | Tibet Rhodiola Pharmaceutical Holding Company | 新活素 | Mainland China | Heart Failure | Chengdu Rhodiola Bio-Pharmaceutical Co Ltd | 2005-04-11 | Heart Failure; Acutely decompensated congestive heart failure | Details | |
| Sodium Nitroprusside | SNP | Approved | F. Hoffmann-La Roche Ltd | Nipride, Nitriate, Nitropress | Mainland China | Heart Failure; Hypertension | China Resources Double-Crane Pharmaceutical Co Ltd | 1974-05-10 | Hypotension; Heart Failure; Schizophrenia; Myocardial Infarction; Hypertension; Pulmonary Edema | Details |
| Carperitide | SUN-4936; SUN-4936h; SUN-4936r; SUN-Y4936r; alpha-hANP; ANF (99-126); ANP (99-126); CDD (99-126) | Approved | Daiichi Sankyo Co Ltd | HANP | Japan | Heart Failure | Daiichi Sankyo Co Ltd | 1995-01-20 | Heart Failure; Respiratory Distress Syndrome, Adult; Cardiomyopathies | Details |
| Recombinant human brain natriuretic peptide (Tibet Rhodiola) | Approved | Tibet Rhodiola Pharmaceutical Holding Company | 新活素 | Mainland China | Heart Failure | Chengdu Rhodiola Bio-Pharmaceutical Co Ltd | 2005-04-11 | Heart Failure; Acutely decompensated congestive heart failure | Details | |
| Sodium Nitroprusside | SNP | Approved | F. Hoffmann-La Roche Ltd | Nipride, Nitriate, Nitropress | Mainland China | Heart Failure; Hypertension | China Resources Double-Crane Pharmaceutical Co Ltd | 1974-05-10 | Hypotension; Heart Failure; Schizophrenia; Myocardial Infarction; Hypertension; Pulmonary Edema | Details |
| Carperitide | SUN-4936; SUN-4936h; SUN-4936r; SUN-Y4936r; alpha-hANP; ANF (99-126); ANP (99-126); CDD (99-126) | Approved | Daiichi Sankyo Co Ltd | HANP | Japan | Heart Failure | Daiichi Sankyo Co Ltd | 1995-01-20 | Heart Failure; Respiratory Distress Syndrome, Adult; Cardiomyopathies | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Recombinant human brain natriuretic peptide (Shanghai Jiao Tong University) | Phase 3 Clinical | Shanghai Jiaotong University | Heart Defects, Congenital; Tetralogy of Fallot | Details | |
| Nesiritide | BNP-32 (human); JNS-004; hBNP; SC-70400 | Phase 2 Clinical | Johnson & Johnson | Myocardial Ischemia; Hyperemia; Heart Failure; Renal Insufficiency; Acutely decompensated congestive heart failure; Sleep Disorders, Circadian Rhythm; Hypertension; Dyspnea; Coronary Disease; Cardiomyopathies; Hyperinsulinism; Cardiovascular Diseases; Obesity; Diabetes Mellitus; Heart Failure, Systolic | Details |
| PL-3994 | PL-3994 | Phase 2 Clinical | Palatin Technologies Inc | Heart Failure; Hypertension; Asthma | Details |
| XXB-750 | XXB-750 | Phase 2 Clinical | Novartis Pharma Ag | Heart Failure; Hypertension | Details |
| GNP | Phase 2 Clinical | Guangzhou Leien Kangya Biomedical Technology Co Ltd | Heart Failure; Acutely decompensated congestive heart failure | Details | |
| REGN-5381 | REGN-5381 | Phase 2 Clinical | Heart Failure | Details | |
| Recombinant human brain natriuretic peptide (Suzhou Landing Bioteh) | Phase 1 Clinical | Suzhou RxD Biopharmaceutical Co Ltd | Heart Failure | Details | |
| REGN-7544 | REGN-7544; REGN7544 | Phase 1 Clinical | Details | ||
| Recombinant human brain natriuretic peptide(Shijiazhuang wotai) | Phase 1 Clinical | Shijiazhuang wotai Biotechnology Co Ltd | Heart Failure; Acutely decompensated congestive heart failure | Details | |
| Recombinant human brain natriuretic peptide (Shanghai Jiao Tong University) | Phase 3 Clinical | Shanghai Jiaotong University | Heart Defects, Congenital; Tetralogy of Fallot | Details | |
| Nesiritide | BNP-32 (human); JNS-004; hBNP; SC-70400 | Phase 2 Clinical | Johnson & Johnson | Myocardial Ischemia; Hyperemia; Heart Failure; Renal Insufficiency; Acutely decompensated congestive heart failure; Sleep Disorders, Circadian Rhythm; Hypertension; Dyspnea; Coronary Disease; Cardiomyopathies; Hyperinsulinism; Cardiovascular Diseases; Obesity; Diabetes Mellitus; Heart Failure, Systolic | Details |
| PL-3994 | PL-3994 | Phase 2 Clinical | Palatin Technologies Inc | Heart Failure; Hypertension; Asthma | Details |
| XXB-750 | XXB-750 | Phase 2 Clinical | Novartis Pharma Ag | Heart Failure; Hypertension | Details |
| GNP | Phase 2 Clinical | Guangzhou Leien Kangya Biomedical Technology Co Ltd | Heart Failure; Acutely decompensated congestive heart failure | Details | |
| REGN-5381 | REGN-5381 | Phase 2 Clinical | Heart Failure | Details | |
| Recombinant human brain natriuretic peptide (Suzhou Landing Bioteh) | Phase 1 Clinical | Suzhou RxD Biopharmaceutical Co Ltd | Heart Failure | Details | |
| REGN-7544 | REGN-7544; REGN7544 | Phase 1 Clinical | Details | ||
| Recombinant human brain natriuretic peptide(Shijiazhuang wotai) | Phase 1 Clinical | Shijiazhuang wotai Biotechnology Co Ltd | Heart Failure; Acutely decompensated congestive heart failure | Details |
This web search service is supported by Google Inc.
A-Z
